Skip to main content

Table 3 Mean (SD) of groups and corresponding mean difference between groups (95 % CI) reported for spasticity and activity clinical measures at baseline (A), post treatment (B) and follow-up (C)

From: The orthotic and therapeutic effects following daily community applied functional electrical stimulation in children with unilateral spastic cerebral palsy: a randomised controlled trial

 

FES

Control

Mean difference (95 % CI)

Between group p value

ASAS gastrocnemiusa

A

2 (1.5-3)

2 (1.5-3)

  

B

1 (0.5-2)

2 (2–2)

-

p = 0.038b

C

2 (0.5-3)

2 (2–3)

-

p = 0.090

Dynamic dorsiflexion ROM (°)

A

0 (10.7)

1.1 (8.8)

  

B

5.9 (9.4)

1.9 (7.1)

4.7 (−1.9 to 11.3)

p = 0.245

C

4.5 (9.8)

−1.8 (10.9)

6.9 (0.4 to 13.6)

p = 0.035b

4SST (seconds)

A

10.9 (2.8)

10.6 (3.3)

  

B

9.0 (2.6)

9.6 (2.1)

−0.1 (−0.2 to 0.03)

p = 0.182

C

8.5 (2.8)

9.1 (2.6)

−0.1 (−0.3 to 0.03)

p = 0.160

Self-report toe draga

A

2 (1.5-4)

4 (2–5)

  

B

2 (1–3)

4 (2.5-5)

-

p = 0.002b

C

2 (1–3.5)

4 (2–4)

-

p = 0.069

CMBS (score out of 96)

A

56.4 (14.8)

53.5 (16.5)

  

B

67.7 (12.8)

56.9 (16.9)

8.3 (3.2 to 13.4)

p < 0.001b

C

70.4 (11.3)

58.9 (16.2)

8.9 (3.8 to 13.9)

p < 0.001b

Self-report fallsa

A

2 (1–3)

3 (2–4)

  

B

2 (1–2.5)

2 (2–3)

-

p = 0.089

C

1.5 (1–2)

2.5 (2–3.5)

-

p = 0.011b

  1. ASAS Australian Spasticity Assessment Scale, ROM Range of Motion, 4SST Four Square Step Test, aMann Whitney U tests with reported medians and IQR; bSignificant difference between the groups p < 0.05; − Calculation and test not indicated; CBMS Community Balance Mobility Scale